PepGen’s $80.1 Million Offering

Sonia Carcano
Tagged:

Paul Hastings LLP advised Leerink Partners on the matter.PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

…

This content is for Standard 1 Year members only.
Login Join Now